Literature DB >> 310671

Sensitive neutralization test for virus antibody. 1. Mumps antibody.

H Sato, P Albrecht, J T Hicks, B C Meyer, F A Ennis.   

Abstract

A sensitive mumps virus plaque neutralization test has been developed based on the potentiation of virus-antibody complexes by heterologous anti-immunoglobulins (AIG). The enhanced neutralization test was approximately 100 times more sensitive than the conventional neutralization test or the hemagglutination-inhibition test. Using AIG against human immunoglobulin G (IgG) or human IgM permitted determination of the relative titers of the two classes of mumps antibody. The test does not require special equipment or expertise and can be readily introduced in virological laboratories.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 310671     DOI： 10.1007/bf01317822

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  24 in total

1.  Microassay of measles and mumps virus and antibody in VERO cells.

Authors:  M T Kenny; K Schell
Journal:  J Biol Stand       Date:  1975

2.  DEVELOPMENT OF AN ATTENUATED MUMPS VIRUS VACCINE. I. DETERMINATION OF NEUTRALIZING SERUM ANTIBODIES AGAINST MUMPS VIRUS.

Authors:  F DEINHARDT; G SHRAMEK
Journal:  J Immunol       Date:  1964-09       Impact factor: 5.422

3.  A study of infections caused by mumps and Newcastle disease viruses. II. Some properties of specific and non-specific serum hemagglutination inhibitor components.

Authors:  H A WENNER; A MONLEY; M H JENSON
Journal:  J Immunol       Date:  1952-04       Impact factor: 5.422

4.  Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure.

Authors:  P Albrecht; F A Ennis; E J Saltzman; S Krugman
Journal:  J Pediatr       Date:  1977-11       Impact factor: 4.406

5.  Infectious virus-antibody complexes: interaction with anti-immunoglobulins, complement, and rheumatoid factor.

Authors:  A L Notkins
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

6.  The fate of sensitized equine arteritis virus following neutralization by complement of anti-IgG serum.

Authors:  A I Radwan; D Burger; W C Davis
Journal:  Virology       Date:  1973-06       Impact factor: 3.616

7.  Neutralization of sensitized lactic dehydrogenase virus by anti-gammglobulin.

Authors:  A L Notkins; M Mage; W K Ashe; S Mahar
Journal:  J Immunol       Date:  1968-02       Impact factor: 5.422

8.  Development and duration of mumps fluorescent antibodies in various immunoglobulin fractions of human serum.

Authors:  G C Brown; J V Baublis; T P O'Leary
Journal:  J Immunol       Date:  1970-01       Impact factor: 5.422

9.  A plaque neutralization test for determining mumps antibodies.

Authors:  F A Ennis; R D Douglas; G L Stewart; H E Hopps; H M Meyer
Journal:  Proc Soc Exp Biol Med       Date:  1968-12

10.  Infectious influenza virus-antibody complex.

Authors:  E Zalan; E Borman; N A Labzoffsky
Journal:  Arch Gesamte Virusforsch       Date:  1971
View more
  9 in total

1.  Epidemiology of mumps in the Netherlands.

Authors:  J H Wagenvoort; M Harmsen; B J Boutahar-Trouw; C A Kraaijeveld; K C Winkler
Journal:  J Hyg (Lond)       Date:  1980-12

2.  Evaluation of humoral immunity to varicella-zoster virus by an enhanced neutralization test and by the fluorescent antibody to membrane antigen test.

Authors:  Y Asano; P Albrecht; L K Vujcic; G V Quinnan; M Takahashi
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

3.  Sensitive hemagglutination inhibition test for mumps antibody.

Authors:  P Albrecht; M Klutch
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

4.  Sensitive neutralization test for rubella antibody.

Authors:  H Sato; P Albrecht; S Krugman; F A Ennis
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

5.  Activation of chicken alternative complement pathway by fowlpox virus-infected cells.

Authors:  H Ohta; C Kai; Y Yoshikawa; K Yamanouchi
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

6.  Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement.

Authors:  A L Frank; J Puck; B J Hughes; T R Cate
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

7.  Sensitive plaque neutralization assay for parainfluenza virus types 1, 2, and 3 and respiratory syncytial virus.

Authors:  J D Hawthorne; P Albrecht
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

Review 8.  Viral immunodiagnosis.

Authors:  A Baumgarten
Journal:  Yale J Biol Med       Date:  1980 Jan-Feb

9.  Safety and Immunogenicity of Human Serum Albumin-Free MMR Vaccine in US Children Aged 12-15 Months.

Authors:  Maurice A Mufson; Clemente Diaz; Michael Leonardi; Christopher J Harrison; Stanley Grogg; Antonio Carbayo; Simon Carlo-Torres; Robert JeanFreau; Ana Quintero-Del-Rio; Gisele Bautista; Michael Povey; Christopher Da Costa; Ouzama Nicholson; Bruce L Innis
Journal:  J Pediatric Infect Dis Soc       Date:  2014-08-07       Impact factor: 3.164
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.